UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 139

Sortiert nach

SCN9A Mutations Define Primary Erythermalgia as a Neuropathic Disorder of Voltage Gated Sodium Channels

Journal of investigative dermatology, 2005-06, Vol.124 (6), p.1333-1338

2005

Volltextzugriff (PDF)

Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial

The Journal of pharmacology and experimental therapeutics, 2001-09, Vol.298 (3), p.1221

2001

Volltextzugriff (PDF)

Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2099-2109

2021

Volltextzugriff (PDF)

United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)

United European Gastroenterology Journal, 2017-03, Vol.5 (2), p.153-199

2017

Volltextzugriff (PDF)

DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy by Disrupting Wnt Signaling

American journal of human genetics, 2015-01, Vol.96 (1), p.81-92

2015

Volltextzugriff (PDF)

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study

Drug safety, 2019-04, Vol.42 (4), p.539-546

2019

Volltextzugriff (PDF)

NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders

The Journal of neuroscience, 2008-10, Vol.28 (43), p.11079-11088

2008

Volltextzugriff (PDF)

Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability

Neurology, 2012-05, Vol.78 (21), p.1635

2012

Volltextzugriff (PDF)

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

Alimentary pharmacology & therapeutics, 2011-08, Vol.34 (3), p.335-343

2011

Volltextzugriff (PDF)

Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release

The Journal of immunology (1950), 2005-05, Vol.174 (10), p.6518-6523

2005

Volltextzugriff (PDF)

Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells

Immunology, 1996-07, Vol.88 (3), p.355-362

1996

Volltextzugriff (PDF)

A Call for a Consortium for Optimal Management of Drug–Drug Interactions in Patient Care

Clinical pharmacology and therapeutics, 2017-09, Vol.102 (3), p.391-394

2017

Volltextzugriff (PDF)

NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease

European Journal of Immunology, 2004-07, Vol.34 (7), p.2052-2059

2004

Volltextzugriff (PDF)

Early prediction of thiopurine‐induced hepatotoxicity in inflammatory bowel disease

Alimentary pharmacology & therapeutics, 2017-02, Vol.45 (3), p.391-402

2017

Volltextzugriff (PDF)

Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

Nature genetics, 2003-03, Vol.33 (3), p.345-347

2003

Volltextzugriff (PDF)

Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia

Brain (London, England : 1878), 2010-06, Vol.133 (6), p.1823-1835

2010

Volltextzugriff (PDF)

Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome

Clinical pharmacology and therapeutics, 2004-05, Vol.75 (5), p.476-483

2004

Volltextzugriff (PDF)

Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey

Intensive care medicine, 2003-07, Vol.29 (7), p.1121-1125

2003

Volltextzugriff (PDF)

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C

Alimentary pharmacology & therapeutics, 2011-12, Vol.34 (11‐12), p.1306-1317

2011

Volltextzugriff (PDF)

Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis

Gut, 2002-05, Vol.50 (5), p.687-692

2002

Volltextzugriff (PDF)

Multiple authorship: the contribution of senior authors

JAMA : the journal of the American Medical Association, 1998-07, Vol.280 (3), p.219

Drenth, J P

1998

Volltextzugriff (PDF)

The revised Atlanta criteria more accurately reflect severity of post-ERCP pancreatitis compared to the consensus criteria

United European gastroenterology journal, 2019-05, Vol.7 (4), p.557-564

2019

Volltextzugriff (PDF)

The association between portal system vein diameters and outcomes in acute pancreatitis

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2018-07, Vol.18 (5), p.494-499

2018

Volltextzugriff (PDF)

Mevalonate kinase deficiency: Evidence for a phenotypic continuum

Neurology, 2004-03, Vol.62 (6), p.994

2004

Volltextzugriff (PDF)

Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome : introducing a vaccination provocation model

Netherlands journal of medicine, 2005-07, Vol.63 (7), p.260-264

2005

Volltextzugriff (PDF)

1 – 25 von 139

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(134)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(139)

Sprache

Englisch
(139)
Japanisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SCN9A Mutations Define Primary Erythermalgia as a Neuropathic Disorder of Voltage Gated Sodium Channels

Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial

Outcome of COVID‐19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)

DCDC2 Mutations Cause a Renal-Hepatic Ciliopathy by Disrupting Wnt Signaling

Prevalence of Drug Prescriptions and Potential Safety in Patients with Cirrhosis: A Retrospective Real-World Study

NaV1.7 Gain-of-Function Mutations as a Continuum: A1632E Displays Physiological Changes Associated with Erythromelalgia and Paroxysmal Extreme Pain Disorder Mutations and Produces Symptoms of Both Disorders

Nav1.7-related small fiber neuropathy: impaired slow-inactivation and DRG neuron hyperexcitability

The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes

Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release

Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells

A Call for a Consortium for Optimal Management of Drug–Drug Interactions in Patient Care

NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease

Early prediction of thiopurine‐induced hepatotoxicity in inflammatory bowel disease

Germline mutations in PRKCSH are associated with autosomal dominant polycystic liver disease

Alternative splicing may contribute to time-dependent manifestation of inherited erythromelalgia

Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome

Serum creatine kinase as predictor of clinical course in rhabdomyolysis: a 5-year intensive care survey

Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon‐alfa‐2a and ribavirin for chronic hepatitis C

Mutations in serine protease inhibitor Kazal type 1 are strongly associated with chronic pancreatitis

Multiple authorship: the contribution of senior authors

The revised Atlanta criteria more accurately reflect severity of post-ERCP pancreatitis compared to the consensus criteria

The association between portal system vein diameters and outcomes in acute pancreatitis

Mevalonate kinase deficiency: Evidence for a phenotypic continuum

Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome : introducing a vaccination provocation model

Suchergebnisse filtern